½ÃÀ庸°í¼­
»óǰÄÚµå
1539338

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)

Obesity Surgery Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ÃÖ±Ù ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡ ´ëÇÑ »ó¼¼ÇÑ Á¶»ç º¸°í¼­¸¦ ¹ßÇ¥ÇÏ¿© ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ±¸Á¶¿Í ÇâÈÄ Àü¸Á¿¡ ´ëÇÑ Ã¶ÀúÇÑ ÀÌÇØ¸¦ Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϸç, °æÀï ȯ°æ¿¡¼­ ¿ìÀ§¸¦ Á¡ÇϰíÀÚ ÇÏ´Â ¾÷°è °ü°èÀÚµéÀÇ ¿ä±¸¿¡ ºÎÀÀÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ¼¼°è ½ÃÀå ¼öÀÍ(2022³â) : 19¾ï ´Þ·¯
  • ÃßÁ¤ ½ÃÀå °¡Ä¡(2033³â) : 32¾ï ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(2022-2033³â CAGR) : 6.0%

ºñ¸¸ ¼ö¼ú ±â±â ¼¼°è ½ÃÀå - Á¶»ç ¹üÀ§

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀº ºñ¸¸ Ä¡·á¸¦ À§ÇÑ ¿Ü°ú ¼ö¼ú¿¡ »ç¿ëµÇ´Â ±â±âÀÇ »ý»ê ¹× À¯Åë¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â ºñ¸¸, ƯÈ÷ ¼Ò¾Æ ¹× ¼ºÀÎÀÇ ºñ¸¸ Áõ°¡¸¦ °ü¸®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ´ç´¢º´, ½ÉÇ÷°üÁúȯ, ƯÁ¤ ¾Ï°ú °°Àº ºñ¸¸°ú °ü·ÃµÈ °Ç°­ ¹®Á¦¿¡ ´ëÇÑ ÀÇ·á ºÎ¹®ÀÇ ´ëÀÀ¿¡ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¾î¸°ÀÌ ¹× ¼ºÀÎÀÇ ºñ¸¸ ¹ß»ý·ü Áõ°¡

Àü ¼¼°èÀûÀ¸·Î ¼Ò¾Æ ¹× ¼ºÀÎ ºñ¸¸ À¯º´·üÀÇ Áõ°¡´Â ºñ¸¸ ¼ö¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇÏ´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ½Ä½À°ü º¯È­¿Í ¿îµ¿·® °¨¼Ò·Î ÀÎÇØ ºñ¸¸À²ÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¾ÕÀ¸·Îµµ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁøÁ¦°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, À¯´Ï¼¼ÇÁ(UNICEF)ÀÇ 2022³â ¼¼°è ºñ¸¸ ¾ÆÆ²¶ó½º(World Obesity Atlas)¿¡ µû¸£¸é, 2030³â±îÁö Àεµ¿¡¼­¸¸ 2,700¸¸ ¸í ÀÌ»óÀÇ ¾î¸°À̰¡ ºñ¸¸ÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ³î¶ó¿î Åë°è´Â È¿°úÀûÀÎ ºñ¸¸ °ü¸® Àü·«ÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ºñ¸¸ ¼ö¼ú ±â±â ¼¼°è ½ÃÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·áºñ ÁöÃâ Áõ°¡ ¹× ÀÎ½Ä °³¼±

Àü ¼¼°èÀûÀ¸·Î, ƯÈ÷ ½ÅÈï±¹°ú ¼±Áø±¹ÀÇ ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ ºñ¸¸ °ü¸®¿Í Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. 1Àδç ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ °³Àΰú ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ¾çÁúÀÇ Ä¡·á ¿É¼ÇÀ» Ãß±¸ÇÔ¿¡ µû¶ó ÷´Ü ºñ¸¸ ¼ö¼ú ±â±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ºñ¸¸°ú °ü·ÃµÈ ´ç´¢º´, ½ÉÇ÷°üÁúȯ, ³úÁ¹Áß°ú °°Àº ½É°¢ÇÑ °Ç°­ À§Çè¿¡ ´ëÇÑ ºñ¸¸ÀÎÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºñ¸¸ ¼ö¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤ºÎ Ä·ÆäÀΰú ÃÖ¼Òħ½À ¼ö¼ú

ºñ¸¸°ú ±× °á°ú¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎ ÁÖµµÀÇ Ä·ÆäÀεµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àεµ ¸¶ÇÏ¶ó½´Æ®¶ó ÁÖ Á¤ºÎÀÇ Áö¿øÀ» ¹Þ´Â ÀεµÀÇ ¶óÆÄ·Î¿Àº£¼Ò ¼¾ÅÍ(LaparoObeso Center)ÀÇ ÇÁ·ÎÁ§Æ®¿Í °°Àº ³ë·ÂÀº ¿Üµý Áö¿ª Áֹε鿡°Ô ºñ¸¸°ú ´ç´¢º´¿¡ ´ëÇØ ±³À°ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. Áß±¹¿¡¼­µµ Áß±¹ ¿µ¾çÇÐȸÀÇ ºñ¸¸ ¿¹¹æ °ü¸® ºÎ¼­´Â ºñ¸¸ À§±â¸¦ ÇØ°áÇϱâ À§ÇÑ ÀÎ½Ä °³¼± Ä·ÆäÀÎÀ» Àü°³Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½ÀÀû üÁß °¨·® ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö´Â °Íµµ ½ÃÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀÇ °úÁ¦

³ôÀº »ý»ê ºñ¿ë°ú Á¦ÇÑµÈ ÀçÁ¤Àû Áö¿ø

½ÃÀåÀÇ ÀáÀç·Â¿¡µµ ºÒ±¸ÇÏ°í ºñ¸¸ ¼ö¼ú±â±¸ÀÇ ³ôÀº ¿¬±¸°³¹ß ¹× »ý»êºñ¿ëÀÌ Å« ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀ» Æ÷ÇÔÇÑ ¿¬±¸°³¹ß Ȱµ¿¿¡ ÇÊ¿äÇÑ ¸·´ëÇÑ ÀçÁ¤Àû ÅõÀÚ´Â Á¦Á¶¾÷üÀÇ ¹ß¸ñÀ» ÀâÀ» ¼ö ÀÖ½À´Ï´Ù. À§ ½½¸®ºê ¼ö¼ú, À§ ¿ìȸ¼ú, À§ ¹êµå Á¶Á¤¼ú°ú °°Àº ¼ö¼úÀÇ ³ôÀº ºñ¿ëµµ ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °í°¡ÀÇ ¼ö¼ú¿¡ ´ëÇÑ ÃæºÐÇÑ ÀçÁ¤Àû Áö¿øÀÌ ¾ø±â ¶§¹®¿¡ ƯÈ÷ ÀÇ·á ÀÚ±ÝÀÌ Á¦ÇÑµÈ Áö¿ª¿¡¼­ ºñ¸¸ ¼ö¼ú ±â±âÀÇ µµÀÔÀÌ Á¦ÇÑ µÉ ¼ö ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé

  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ºñ¸¸ ¼ö¼ú ±â±â äÅÃÀ» ÁÖµµÇÏ´Â ¼ÒºñÀÚÃþÀº?
  • ¼ö¼ú ±â¼úÀÇ ¹ßÀüÀº °æÀï »óȲ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ½À´Ï±î?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ ÁÖ¿ä ±â¾÷Àº ¾îµðÀ̸ç, ½ÃÀå ÁöÀ§¸¦ À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇϰí Àִ°¡?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§/ºÐ·ù
  • ½ÃÀå Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
  • Æ÷ÇÔ°ú Á¦¿Ü

Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
  • Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ

Á¦4Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • »ý»ê Àü·«
  • º¼·ý ¼Òºñ
  • »ý»ê ºñ¿ë
  • ÆÄÀÌÇÁ¶óÀÎ Æò°¡
  • ƯÇ㠺м®
  • PESTEL ºÐ¼®
  • Porters ºÐ¼®

Á¦5Àå ½ÃÀå ¹è°æ

  • °Å½Ã°æÁ¦ ¿äÀÎ
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
  • ½ÃÀå ¿ªÇÐ

Á¦6Àå COVID-19 À§±â ºÐ¼®

  • COVID-19¿Í ¿µÇ⠺м®
  • 2024³â ½ÃÀå ½Ã³ª¸®¿À

Á¦7Àå ¼¼°è ½ÃÀå(¼ö·®) ºÐ¼®

  • ½ÃÀå(¼ö·®) ºÐ¼®, 2019-2023³â
  • ½ÃÀå(¼ö·®) ¿¹Ãø, 2024-2033³â
    • Àü³âºñ ¼ºÀå µ¿Ç⠺м®

Á¦8Àå ¼¼°è ½ÃÀå - °¡°Ý ºÐ¼®

  • ÀÇ·á±â±â/ÀÓÇöõÆ®º° Áö¿ªº° °¡°Ý ºÐ¼®
  • °¡°Ý ³»¿ª
    • Á¦Á¶¾÷ü ·¹º§
    • À¯Åë¾÷ü ·¹º§
  • ¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
  • °¡°Ý ¼³Á¤ °¡Á¤

Á¦9Àå ¼¼°è ½ÃÀå ¼ö¿ä(±Ý¾× ¹× ±Ô¸ð) ºÐ¼®

  • ½ÃÀå(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ½ÃÀå(±Ý¾×) ¿¹Ãø, 2024-2033³â
    • Àü³âºñ ¼ºÀå µ¿Ç⠺м®
    • Àý´ëÀû ¼öÀÍ ±âȸ

Á¦10Àå ÀÇ·á±â±â/ÀÓÇöõÆ®º° : ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
    • À§Ç³¼±
    • À§¹êµå
    • ½ºÅ×ÀÌÇà µð¹ÙÀ̽º
  • ÀÇ·á±â±â¡¤ÀÓÇöõÆ®º° ½ÃÀå ¸Å·Â ºÐ¼®

Á¦11Àå ÃÖÁ¾»ç¿ëÀÚº° : ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
    • º´¿ø
    • Àü¹® Ŭ¸®´Ð
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ¸Å·Â ºÐ¼®

Á¦12Àå Áö¿ªº° : ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ
    • ¿À¼¼¾Æ´Ï¾Æ
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
  • Áö¿ªº° ½ÃÀå ¸Å·Â ºÐ¼®

Á¦13Àå ºÏ¹Ì ½ÃÀå ºÐ¼®

Á¦14Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®

Á¦15Àå À¯·´ ½ÃÀå ºÐ¼®

Á¦16Àå µ¿¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦17Àå ³²¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦18Àå ¿À¼¼¾Æ´Ï¾Æ ½ÃÀå

Á¦19Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) ½ÃÀå ºÐ¼®

Á¦20Àå ½ÃÀå ±¸Á¶ ºÐ¼®

  • ±â¾÷ °èÃþº° ½ÃÀå ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÀÔÁö ºÐ¼®

Á¦21Àå °æÀï ºÐ¼®

  • °æÀï ´ë½Ãº¸µå
  • °æÀï º¥Ä¡¸¶Å©
  • °æÀï »ó¼¼
    • Johnson & Johnson
    • Medtronic, Inc.
    • Apollo Endosurgery Inc.
    • Aspire Bariatrics
    • Spatz FGIA Inc.
    • MetaCure
    • IntraPace Inc.
    • Other

Á¦22Àå »ç¿ëµÇ´Â °¡Á¤°ú µÎ¹®ÀÚ¾î

Á¦23Àå Á¶»ç ¹æ¹ý

ksm 24.09.20

Persistence Market Research has recently published an in-depth report on the global obesity surgery devices market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a thorough understanding of the market structure and future outlook, catering to the needs of industry stakeholders looking to stay ahead in a competitive landscape.

Key Insights:

  • Global Market Revenue (2022): US$ 1.9 Billion
  • Estimated Market Value (2033): US$ 3.2 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 6.0%

Global Obesity Surgery Devices Market - Report Scope:

The obesity surgery devices market focuses on the production and distribution of devices used in surgical procedures aimed at treating obesity. These devices are critical in managing the increasing global prevalence of obesity, particularly in children and adults, and are integral to the healthcare sector's response to obesity-related health issues such as diabetes, cardiovascular diseases, and certain cancers.

Market Growth Drivers:

Increasing Incidence of Obesity in Children and Adults

The rising prevalence of obesity among children and adults worldwide is a significant factor driving the demand for obesity surgery devices. Poor dietary habits and reduced physical activity are leading to a surge in obesity rates, which is expected to remain a key driver of market growth. For instance, according to UNICEF's World Obesity Atlas for 2022, by 2030, more than 27 million children in India alone are expected to be obese. This alarming statistic underscores the growing need for effective obesity management strategies, fueling the global market for obesity surgery devices.

Rising Healthcare Spending and Awareness

As healthcare costs rise globally, particularly in emerging and developed economies, there is an increasing emphasis on obesity management and treatment. Higher per capita healthcare spending is anticipated to drive the adoption of advanced obesity surgery devices, as individuals and healthcare providers seek high-quality treatment options. Moreover, growing awareness among overweight individuals about the severe health risks associated with obesity, such as diabetes, cardiovascular diseases, and strokes, is expected to boost the demand for obesity surgery devices.

Government Campaigns and Minimally Invasive Procedures

Government-led campaigns to raise awareness about obesity and its consequences are also contributing to market growth. Initiatives like the LaparoObeso Centre's project in India, supported by the Maharashtra State Government, aim to educate remote populations about obesity and diabetes. Similarly, in China, the Obesity Prevention and Control Section of the Chinese Nutrition Society has launched awareness campaigns to address the obesity crisis. Additionally, the increasing preference for minimally invasive weight loss procedures is expected to further propel the market.

Market Challenges:

High Production Costs and Limited Financial Support

Despite the market's potential, the high cost of research, development, and production of obesity surgery devices poses a significant challenge. The substantial financial investment required for R&D activities, including clinical trials, can be a deterrent for manufacturers. The high cost of surgical procedures, such as gastric sleeve surgery, gastric bypass surgery, and adjustable gastric banding, may also limit market growth. The lack of adequate financial support for these expensive surgeries can restrict the adoption of obesity surgery devices, particularly in regions with limited healthcare funding.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global obesity surgery devices market?
  • Which consumer segments are leading the adoption of obesity surgery devices?
  • How are advancements in surgical technology influencing the competitive landscape?
  • Who are the key players in the global obesity surgery devices market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global obesity surgery devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global obesity surgery devices market are focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a competitive edge. Companies are investing heavily in R&D to develop next-generation devices that offer improved safety, efficacy, and patient outcomes. Collaborations with healthcare providers and government agencies are enhancing market credibility and driving the adoption of these advanced surgical devices. Additionally, leveraging digital marketing and targeted outreach to both healthcare professionals and patients is key to strengthening market positioning and consumer engagement.

Key Companies Profiled:

  • Johnson & Johnson
  • Medtronic, Inc.
  • Apollo Endosurgery Inc.
  • Aspire Bariatrics
  • Spatz FGIA Inc.
  • MetaCure
  • IntraPace Inc.
  • Other

Key Segments Covered in Obesity Surgery Devices Industry Research

Medical Devices/ Implants:

  • Gastric Balloons
  • Gastric Bands
  • Stapling Devices

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage/Taxonomy
  • 2.2. Market Definition/Scope/Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation/Development Trends

4. Value Added Insights

  • 4.1. Production Strategy
  • 4.2. Volume Consumption
  • 4.3. Production Cost
  • 4.4. Pipeline Assessment
  • 4.5. Patent Analysis
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Technological Innovation in Surgery Devices
    • 5.2.2. Regulatory Imposition
    • 5.2.3. Increasing Spending on Research and Development
    • 5.2.4. Increasing Prevalence of Obesity
    • 5.2.5. Increasing Chronic Diseases Due to Obesity
    • 5.2.6. High Rate of Manufacturing
    • 5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
  • 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis By Medical Devices/Implants
  • 8.2. Price Break up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Medical Devices/Implants

  • 10.1. Introduction/Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Medical Devices/Implants, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Medical Devices/Implants, 2024-2033
    • 10.3.1. Gastric Balloons
    • 10.3.2. Gastric Bands
    • 10.3.3. Stapling Devices
  • 10.4. Market Attractiveness Analysis By Medical Devices/Implants

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction/Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Clinics
    • 11.3.3. Ambulatory Surgical Centers
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Medical Devices/Implants
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Medical Devices/Implants
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Medical Devices/Implants
        • 13.8.1.2.2. By End User
    • 13.8.2. Canada Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Medical Devices/Implants
        • 13.8.2.2.2. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Medical Devices/Implants
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Medical Devices/Implants
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Medical Devices/Implants
        • 14.8.1.2.2. By End User
    • 14.8.2. Brazil Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Medical Devices/Implants
        • 14.8.2.2.2. By End User
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Medical Devices/Implants
        • 14.8.3.2.2. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Medical Devices/Implants
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Medical Devices/Implants
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Medical Devices/Implants
        • 15.8.1.2.2. By End User
    • 15.8.2. Italy Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Medical Devices/Implants
        • 15.8.2.2.2. By End User
    • 15.8.3. France Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Medical Devices/Implants
        • 15.8.3.2.2. By End User
    • 15.8.4. U.K. Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Medical Devices/Implants
        • 15.8.4.2.2. By End User
    • 15.8.5. Spain Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Medical Devices/Implants
        • 15.8.5.2.2. By End User
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Medical Devices/Implants
        • 15.8.6.2.2. By End User
    • 15.8.7. Russia Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Medical Devices/Implants
        • 15.8.7.2.2. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Medical Devices/Implants
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Medical Devices/Implants
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Medical Devices/Implants
        • 16.8.1.2.2. By End User
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Medical Devices/Implants
        • 16.8.2.2.2. By End User
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Medical Devices/Implants
        • 16.8.3.2.2. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Medical Devices/Implants
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Medical Devices/Implants
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Medical Devices/Implants
        • 17.8.1.2.2. By End User
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Medical Devices/Implants
        • 17.8.2.2.2. By End User
    • 17.8.3. Malaysia Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Medical Devices/Implants
        • 17.8.3.2.2. By End User
    • 17.8.4. Thailand Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Medical Devices/Implants
        • 17.8.4.2.2. By End User

18. Oceania Market 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Medical Devices/Implants
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Medical Devices/Implants
    • 18.4.3. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Medical Devices/Implants
        • 18.8.1.2.2. By End User
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Medical Devices/Implants
        • 18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. North Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Medical Devices/Implants
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Medical Devices/Implants
    • 19.4.3. By End User
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Medical Devices/Implants
        • 19.8.1.2.2. By End User
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Medical Devices/Implants
        • 19.8.2.2.2. By End User
    • 19.8.3. South Africa Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Medical Devices/Implants
        • 19.8.3.2.2. By End User
    • 19.8.4. North Africa Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Medical Devices/Implants
        • 19.8.4.2.2. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Johnson & Johnson
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Sales Footprint
      • 21.3.1.4. Key Financials
      • 21.3.1.5. SWOT Analysis
      • 21.3.1.6. Strategy Overview
    • 21.3.2. Medtronic, Inc.
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Sales Footprint
      • 21.3.2.4. Key Financials
      • 21.3.2.5. SWOT Analysis
      • 21.3.2.6. Strategy Overview
    • 21.3.3. Apollo Endosurgery Inc.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Sales Footprint
      • 21.3.3.4. Key Financials
      • 21.3.3.5. SWOT Analysis
      • 21.3.3.6. Strategy Overview
    • 21.3.4. Aspire Bariatrics
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Sales Footprint
      • 21.3.4.4. Key Financials
      • 21.3.4.5. SWOT Analysis
      • 21.3.4.6. Strategy Overview
    • 21.3.5. Spatz FGIA Inc.
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Sales Footprint
      • 21.3.5.4. Key Financials
      • 21.3.5.5. SWOT Analysis
      • 21.3.5.6. Strategy Overview
    • 21.3.6. MetaCure
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Sales Footprint
      • 21.3.6.4. Key Financials
      • 21.3.6.5. SWOT Analysis
      • 21.3.6.6. Strategy Overview
    • 21.3.7. IntraPace Inc.
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Sales Footprint
      • 21.3.7.4. Key Financials
      • 21.3.7.5. SWOT Analysis
      • 21.3.7.6. Strategy Overview
    • 21.3.8. Other
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Sales Footprint
      • 21.3.8.4. Key Financials
      • 21.3.8.5. SWOT Analysis
      • 21.3.8.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦